期刊文献+

YKL-40在妇科恶性肿瘤中的表达和意义 被引量:5

The Research Progress of Relationship between YKL-40 and Gynecological Diseases
下载PDF
导出
摘要 YKL-40为哺乳动物几丁质酶样蛋白家族成员之一,由巨噬细胞、中性粒细胞、软骨细胞、内皮细胞、血管平滑肌细胞及一些恶性肿瘤细胞分泌。通过免疫组化法发现,YKL-40在人体多种组织中有不同程度的表达。健康的年轻人群中,血清YKL-40呈低表达且无性别差异。子宫内膜异位症患者其异位内膜腺体的上皮细胞胞质中,子宫腺肌病在位内膜、异位内膜腺上皮细胞胞质以及卵巢癌、子宫内膜癌癌组织中,YKL-40皆呈高表达;在卵巢癌、子宫内膜癌及宫颈癌患者的血清中,YKL-40水平升高,且与生存期缩短相关,治疗前的血清YKL-40水平升高预示着预后不良。 YKL-40 is one of mammalian chitnase members and secreted by macrophage, neutrocyte, chondrocyte, endotheliocyte ,vascular smooth muscle cell and some entity tumor cells. Immunohistochemical assay has found that YKL-40 is expressed in many human tissues with a varying degree. In healthy young group ,the expression of serum YKL-40 is in low level and has no deference between male and female. Studies suggest that there are a high expression of YKL-40 protein in the peri- toneum of peritoneal endometriosis, eutopic and eetopie endometrium of adenomyosis ,ovarian cancer tissues and endometrial cancer tissues. Serum YKL-40 is elevated in ovarian cancer, endometrial cancer and cervical cancer and is related with short- ened survival, elevated serum YKL-40 level before treatment indicates a poor prognosis.
作者 尹绪爱 干宁
出处 《国际妇产科学杂志》 CAS 2013年第2期146-148,155,共4页 Journal of International Obstetrics and Gynecology
关键词 糖蛋白类 生殖器肿瘤 女(雌)性 子宫内膜肿瘤 卵巢肿瘤 宫颈肿瘤 子宫内膜异位症 Glyeoproteins Genital neoplasms, female Endometrial neoplasms Ovarian neoplasms Uterine cervical neoplasms Endometriosis
  • 相关文献

参考文献2

二级参考文献20

  • 1杨国奋,李晓明,谢丹,朝葵,蔡鹏宇.卵巢癌组织中clusterin蛋白表达和细胞凋亡检测[J].中国肿瘤临床,2007,34(12):674-676. 被引量:17
  • 2Walsh JM, Dolan NC, Charney P, et al. Update in womenE's health [J]. Ann Int Med, 2000, 133(10):808-814.
  • 3MenonU, Jacobs IJ. Recent developments in ovarian cancer screening [J]. Curr Opin Obstet Gynaecol, 2000, 12(1) : 39-42.
  • 4Dupont J, Tanwar MK, Thaler HT, et al. Early detection and prognosis of ovarian cancer using serum YKL-40 [J]. J Clin Oncl, 2004,22(16) : 3330-3339.
  • 5Johansen JS, Drivsholm L, Price PA, et al. High serum YKL- 40 level in patients with small cell lung cancer is related to early death [J]. Lung Cancer, 2004,46(3) :333-340.
  • 6Diefenbach CS, Shah Z, Iasonos A, et al. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer [J]. Gynecol Oncol, 2007,104(2):435-442.
  • 7Lau SH, Sham JS, Xie D, et al. Clusterin plays an important role in hepatocellular carcinoma metastasis [J]. Oncogene, 2006,25(8) : 1242-1250.
  • 8Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer [J]. Dan Med Bull, 2006,53(2):172-209.
  • 9Johansen JS, Jensen BV, Roslind A, et al. Serum YKL-40, a new prognostic biomarker in cancer patients? [J]. Cancer Epidemiol Biomarkers Prov, 2006,15(2) : 194-202.
  • 10Dehn H, Hogdall E V, Johansen JS, et al. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer [J]. Acta Obstec Gynecol Stand, 2003,82(3) : 287-293.

共引文献16

同被引文献140

  • 1王士奎,王汉潜.几丁质及脱乙酰几丁质的微生物降解作用[J].微生物学通报,1994,21(3):180-183. 被引量:20
  • 2韩守威,何斌,唐茜萍,刘珊玲,彭芝兰,曹泽毅.女性生殖系统恶性肿瘤组织胞浆雌激素及孕激素受体的研究[J].中华妇产科杂志,1994,29(1):12-15. 被引量:27
  • 3王治伟,刘志敏.微生物几丁质酶研究进展[J].生物技术通讯,2006,17(3):439-442. 被引量:29
  • 4JEON Y T, PARK I A, KIM Y B, et al. Steroid receptor expres- sions in endometrial cancer: clinical significance and epidemiologi- cal implication [ J ]. Cancer Lett, 2006, 239 (2) : 198 - 204.
  • 5ZANNONI G F, MONTEROSSI G, DE STEFANO I, et al. The expression ratios of estrogen receptor alpha (ERalpha) to estrogen receptor betal ( ERbetal ) and ERa]pha to ERbeta2 identify poor clinical outcome in endometrioid endometrial eaneer[ J ]. Hum Pathol, 2013, 44(6) : 1047 - 1054.
  • 6JANZEN D M, ROSALES M A, PAIK D Y, et al. Progesterone receptor signaling in the microenvironment of endometr/al cancer influences its response to hormonal therapy [ J ]. Cancer Res, 2013, 73(15) : 4697 -4710.
  • 7FRASCA F, PANDINI G, SCIACCA L, et al. The role of insulin receptors and IGF - I receptors in cancer and other diseases [ J ]. Arch Physiol Biochem, 2008, 114(1 ) : 23 -37.
  • 8WANG C F, ZHANG G, ZHAO L J, et al. Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth[J]. PLoS One, 2013, 8(8) : e69001.
  • 9MALAGUARNERA R, BELFIORE A. The insulin receptor: a new target for cancer therapy [ J ]. Front Endocrinol (Lausanne) , 2011, 2.- 93.
  • 10DUK J M, AALDERS J G, FLEUREN G J, et al. CA 125: a use- ful marker in endometrial carcinoma [ J ]. Am J Obstet Gynecol, 1986, 155(5): 1097-1102.

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部